Burden of serious infections in adults with systemic lupus erythematosus: A national population-based study, 1996-2011

Arthritis Care and Research

Volumn 67, Issue 8, 2015, Pages 1078-1085

  Tektonidou, Maria G ^a   Wang, Zhong ^b   Dasgupta, Abhijit ^b   Ward, Michael M ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; DISEASE SURVEILLANCE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MORTALITY; OPPORTUNISTIC INFECTION; PNEUMONIA; POPULATION RESEARCH; RISK ASSESSMENT; SEPSIS; SKIN INFECTION; SYSTEMIC LUPUS ERYTHEMATOSUS; TREND STUDY; URINARY TRACT INFECTION; COMPLICATION; COST OF ILLNESS; HOSPITAL MORTALITY; LUPUS ERYTHEMATOSUS, SYSTEMIC; TRENDS; UNITED STATES;

COST OF ILLNESS; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; INFECTION; LUPUS ERYTHEMATOSUS, SYSTEMIC; UNITED STATES;

EID: 84937914733     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22575     Document Type: Article

References (45)

1. Lee J, Dhillon N, Pope J., All-cause hospitalizations in systemic lupus erythematosus from a large Canadian referral centre. Rheumatology (Oxford) 2013; 52: 905-9.
2. Goldblatt F, Chambers S, Rahman A, Isenberg DA., Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality. Lupus 2009; 18: 682-9.
3. Edwards CJ, Lian TY, Badsha H, Teh CL, Arden N, Chng HH., Hospitalization of individuals with systemic lupus erythematosus: characteristics and predictors of outcome. Lupus 2003; 12: 672-6.
4. Gladman DD, Hussain F, Ibanez D, Urowitz MB., The nature and outcome of infection in systemic lupus erythematosus. Lupus 2002; 11: 234-9.
5. Petri M, Genovese M., Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins Lupus Cohort. J Rheumatol 1992; 19: 1559-65.
6. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al., Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 2003; 82: 299-308.
7. Alarcon GS, McGwin G Jr, Bastian HM, Roseman J, Lisse J, Fessler BJ, et al., for the LUMINA Study Group. Systemic lupus erythematosus in three ethnic groups. VIII. Predictors of early mortality in the LUMINA cohort. Arthritis Rheum 2001; 45: 191-202.
8. Ward MM., Avoidable hospitalizations in patients with systemic lupus erythematosus. Arthritis Rheum 2008; 59: 162-8.
9. Ruiz-Irastorza G, Olivares N, Ruiz-Arruza I, Martinez-Berriotxoa A, Egurbide MV, Aguirre C., Predictors of major infections in systemic lupus erythematosus. Arthritis Res Ther 2009; 11: R109.
10. Jeong SJ, Choi H, Lee HS, Han SH, Chin BS, Baek JH, et al., Incidence and risk factors of infection in a single cohort of 110 adults with systemic lupus erythematosus. Scand J Infect Dis 2009; 41: 268-74.
11. Noel V, Lortholary O, Casassus P, Cohen P, Genereau T, Andre MH, et al., Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus. Ann Rheum Dis 2001; 60: 1141-4.
12. Bosch X, Guilabert A, Pallares L, Cerveral R, Ramos-Casals M, Bove A, et al., Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients. Lupus 2006; 15: 584-9.
13. Navarro-Zarza JE, Alvarez-Hernandez E, Casasola-Vargas JC, Estrada-Castro E, Burgos-Vargas R., Prevalence of community-acquired and nosocomial infections in hospitalized patients with systemic lupus erythematosus. Lupus 2010; 19: 43-8.
14. Janwityanuchit S, Totemchokchyakarn K, Krachangwongchai K, Vatanasuk M., Infection in systemic lupus erythematosus. J Med Assoc Thai 1993; 76: 542-8.
15. Pryor BD, Bologna SG, Kahl LE., Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 1475-82.
16. Christensen KL, Holman RC, Steiner CA, Sejvar JJ, Stoll BJ, Schonberger LB., Infectious disease hospitalizations in the United States. Clin Infect Dis 2009; 49: 1025-35.
17. Martin GS, Mannino DM, Eaton S, Moss M., The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546-54.
18. Sogaard M, Nielsen RB, Schonheyder HC, Norgaard M, Thomsen RW., Nationwide trends in pneumonia hospitalization rates and mortality, Denmark 1997-2011. Respir Med 2014; 108: 1214-22.
19. Stevenson EK, Rubenstein AR, Radin GT, Wiener RS, Walkey AJ., Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis. Crit Care Med 2014; 42: 625-31.
20. Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, et al., The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med 2010; 38: 367-74.
21. Agency for Healthcare Research and Quality. HCUP Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP), 2002-2011. URL: www.hcup-us.ahrq.gov/nisoverview.jsp.
22. Schneeweiss S, Robicsek A, Scranton R, Zuckerman D, Solomon DH., Veterans' Affairs hospital discharge databases coded serious bacterial infections accurately. J Clin Epidemiol 2007; 60: 397-409.
23. Grijalva CG, Chung CP, Stein CM, Gideon PS, Dyer SM, Mitchel EF Jr, et al., Computerized definitions showed high positive predictive values for identifying hospitalizations for congestive heart failure and selected infections in Medicaid enrollees with rheumatoid arthritis. Pharmacoepidemiol Drug Saf 2008; 17: 890-5.
24. Patkar NM, Curtis JR, Teng GG, Allison JJ, Saag M, Martin C, et al., Administrative codes combined with medical records based criteria accurately identified bacterial infections among rheumatoid arthritis patients. J Clin Epidemiol 2009; 62: 321-7.
25. Knight AM, Weiss PF, Morales KH, Keren R., National trends in pediatric systemic lupus erythematosus hospitalization in the United States: 2000-2009. J Rheumatol 2014; 41: 539-46.
26. Elixhauser A, Steiner C, Harris DR, Coffey RM., Comorbidity measures for use with administrative data. Med Care 1998; 36: 8-27.
27. Van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ., A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care 2009; 47: 626-33.
28. Ward MM., Development and testing of a systemic lupus-specific risk adjustment index for in-hospital mortality. J Rheumatol 2000; 27: 1408-13.
29. Lim SS, Bayakly AR, Helmick CG, Gordon C, Easley KA, Drenkard C., The incidence and prevalence of systemic lupus erythematosus, 2002-2004: The Georgia Lupus Registry. Arthritis Rheum 2014; 66: 357-68.
30. Somers EC, Marder W, Cagnoli P, Lewis EE, DeGuire P, Gordon C, et al., Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance Program. Arthritis Rheum 2014; 66: 369-78.
31. Urowitz MB, Gladman DD, Tom BD, Ibanez D, Farewell VT., Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. J Rheumatol 2008; 35: 2152-8.
32. Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, et al., Mortality in systemic lupus erythematosus. Arthritis Rheum 2006; 54: 2550-7.
33. Pineau CA, Bernatsky S, Abrahamowicz M, Neville C, Karp I, Clarke AE., A comparison of damage accrual across different calendar periods in systemic lupus erythematosus patients. Lupus 2006; 15: 590-4.
34. Chambers SA, Allen E, Rahman A, Isenberg D., Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years. Rheumatology (Oxford) 2009; 48: 673-5.
35. Mak A, Cheung MW, Chiew HJ, Liu Y, Ho RC., Global trend of survival and damage of systemic lupus erythematosus: meta-analysis and meta-regression of observational studies from the 1950s to 2000s. Semin Arthritis Rheum 2012; 41: 830-9.
36. Zandman-Goddard G, Shoenfeld Y., Infections and SLE. Autoimmunity 2005; 38: 473-85.
37. Buchacz K, Baker RK, Moorman AC, Richardson JT, Wood KC, Holmberg SD, et al., on behalf of HIV Outpatient Study (HOPS) Investigators. Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994-2005. AIDS 2008; 22: 1345-54.
38. Barber C, Gold WL, Fortin PR., Infections in the lupus patient: perspectives on prevention. Curr Opin Rheumatol 2011; 23: 358-65.
39. Yurkovich M, Vostretsova K, Chen W, Avina-Zubieta JA., Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies. Arthritis Care Res (Hoboken) 2014; 66: 608-16.
40. Lindenauer PK, Lagu T, Shieh MS, Pekow PS, Rothberg MB., Association of diagnostic coding with trends in hospitalizations and mortality of patients with pneumonia, 2003-2009. JAMA 2012; 307: 1405-13.
41. Rahier JF, Magro F, Abreu C, Armuzzi A, Ben-Horin S, Chowers Y, et al., European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis 2014; 8: 443-68.
42. Masur H, Brooks JT, Benson CA, Holmes KK, Pau AK, Kaplan JE., Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2014; 58: 1308-11.
43. Mosca M, Tani C, Aringer M, Bombardieri S, Boumpas D, Brey R, et al., European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis 2010; 69: 1269-74.
44. Houssiau FA, Isenberg D., Towards treating lupus nephritis without oral steroids: a dream-come-true? Ann Rheum Dis 2013; 72: 1271-2.
45. Kobashigawa JA., Strategies in immunosuppression after heart transplantation: is less better? Circ Heart Fail 2011; 4: 111-3.